未找到相关数据
Randomized phase II study of danusertib (D) in second-line metastatic castration- resistant prostate cancer (CRPC).
被引：4
作者：
Bleuse, J. P.
Meulenbeld, H. J.
Vinci, E. M.
Raymond, E.
Vitali, G.
Santoro, A.
Dogliotti, L.
Berardi, R.
Cappuzzo, F.
Tagawa, S. T.
Sternberg, C. N.
Jannuzzo, M. G.
Mariani, M.
Petroccione, A.
De Wit, R.
机构：
[1] Ctr Lutte Canc Val dAurelle, Montpellier, France
[2] Erasmus MC, Rotterdam, Netherlands
[3] Osped Misericordia & Dolce, Prato, Italy
[4] Beaujon Univ Hosp, Clichy, France
[5] Ist Sci San Raffaele, I-20132 Milan, Italy
[6] Humanitas Canc Ctr, Rozzano, Italy
[7] Osped San Luigi Gonzaga, Orbassano, Italy
[8] AO Osped Riuniti Univ Politecn Marche, Clin Oncol Med, Ancona, Italy
[9] Ist Toscano Tumori Osped Civile Livorno, Livorno, Italy
[10] Weill Cornell Med Coll, New York, NY USA
[11] San Camillo Forlanini Hosp, Rome, Italy
[12] Nerviano Med Sci, Nerviano, Italy
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.4628
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4628
引用
收藏
页数：1
相关论文